Study Of An Investigational Drug For Primary Progressive Multiple Sclerosis
Seeking men and women aged 18-55 for a study of an investigational drug for primary progressive multiple sclerosis.
Seeking men and women aged 18-55 for a study of an investigational drug for primary progressive multiple sclerosis.
Seeking women and men who have started ocrelizumab treatment for their Multiple Sclerosis (MS) within the past month or people whose MS is being being treated with therapies other than ocrelizumab for a study looking at the incidence of cancer in the future.